• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

More than half of all opioid prescriptions go to people with mental illness

Bioengineer by Bioengineer
June 27, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ANN ARBOR–Fifty-one percent of all opioid medications distributed in the U.S. each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.

"Despite representing only 16 percent of the adult population, adults with mental health disorders receive more than half of all opioid prescriptions distributed each year in the United States," said Matthew Davis, lead author of the study and assistant professor at the U-M School of Nursing.

Overall, of the 115 million prescriptions written for opiates each year, 60 million are written for adults with mental illness.

The study, "Prescription opioid use among adults with mental health disorders in the United States," is among the first to show the extent to which the population of Americans with mental illness use opioids. It will be published online July 6 in the Journal of the American Board of Family Medicine.

Researchers found that among the 38.6 million Americans diagnosed with mental health disorders, more than 7 million, or 18 percent, are prescribed opioids each year. By comparison, only 5 percent of adults without mental disorders are likely to use prescription opioids.

"Because of the vulnerable nature of patients with mental illness, such as their susceptibility for opioid dependency and abuse, this finding warrants urgent attention to determine if the risks associated with such prescribing are balanced with therapeutic benefits," said study co-author Brian Sites, an anesthesiologist at Dartmouth-Hitchcock Medical Center.

The connection between mental illness and opioid prescribing is particularly concerning because mental illness is also a prominent risk factor for overdose and other adverse opioid-related outcomes, Sites and Davis say.

###

Media Contact

Laura Bailey
[email protected]
734-647-1848
@umich

http://www.umich.edu/

http://dx.doi.org/10.3122/jabfm.2017.04.170112

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Survey Reveals Strong American Support for Autism Research, Yet Brain Donation Remains Overlooked as Essential for Progress

April 1, 2026

Impact of Antibiotic Use on Mental Health During Pregnancy: New Insights

April 1, 2026

Tracking Research on Adult Outcomes After Complex Perinatal History

April 1, 2026

Inequities in Family Engagement Within the NICU

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Survey Reveals Strong American Support for Autism Research, Yet Brain Donation Remains Overlooked as Essential for Progress

Impact of Antibiotic Use on Mental Health During Pregnancy: New Insights

Unveiling How Two Genes Collaborate to Shape Dental and Facial Features

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.